848
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11–15 years after primary immunization; China, 2009–2011

, , , , , , , , & show all
Pages 1114-1119 | Received 24 May 2014, Accepted 20 Sep 2014, Published online: 27 May 2015

References

  • El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142:1264-73; PMID:22537432; http://dx.doi.org/10.1053/j.gastro.2011.12.061
  • Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009; 49(5Suppl):S13-S21; PMID:19399811; http://dx.doi.org/10.1002/hep.22881
  • ZC Dai, QG Ming. Chinese hepatitis B viral serum epidemiology investigation report. Beijing: Taylor & Francis. 1997; 39-58.
  • Krugman S, Overby LR, Mushahwar IK, Ling CM, Frosner GG, Deinhardt F. Viral hepatitis, typeB. Studies on natural history and prevention re-examined. N Engl J Med 1979; 300: 101-6; PMID:758598; http://dx.doi.org/10.1056/NEJM197901183000301
  • Tabor E, Hoofnagle JH, Barker LF, Pineda-Tamondong G, Nath N, Smallwood LA, et al. Antibody to hepatitis B core antigen in blood donors with a history of hepatitis. Transfusion 1981;21:366-371; PMID:7233523; http://dx.doi.org/10.1046/j.1537-2995.1981.21381201816.x
  • H Zhuang. Hepatitis B vaccination in China. Basic Medical Sciences and Clinics 2004; 24(2):136-40.
  • Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Reprint of: Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination. Vaccine 2013;31 Suppl 9:J21-8; PMID:23948229; http://dx.doi.org/10.1016/j.vaccine.2013.08.012
  • Lu L , Chen YH, Liu X, He JX . Research of hepatitis B vaccine immune effect. Chinese Journal of Public Health Management 2006; 22(6):485-7.
  • Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol 2009; 50(4):805-16; PMID:19231008; http://dx.doi.org/10.1016/j.jhep.2009.01.002
  • Ma JC , Liu HB, Zhang YL , Meng ZD , Han CQ, Zhang YW et al. Rural neonatal hepatitis b vaccine at 14 years after the immune effect evaluation. Chinese Immunizat. 2002, 8(4):181-4
  • Immunisation against hepatitis B. Lancet 1988; i:875-6. PMID: 2895375
  • Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, Ostrow DG, O'Malley PM, Penley KA, Altman NL, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14; PMID:2941687; http://dx.doi.org/10.1056/NEJM198607243150401
  • Yoshida T, Saito I. Hepatitis B booster vaccination for healthcare workers. Lancet 2000; 355:1464; PMID:10791552; http://dx.doi.org/10.1016/S0140-6736(05)74663-8
  • Are booster immunisations needed for lifelong hepatitis B immunity? European consensus group on hepatitis B immunity. Lancet 2000; 355(9203):561-5; PMID:10683019; http://dx.doi.org/10.1016/S0140-6736(99)07239-6
  • Chaves SS, Groeger J, Helgenberger L, Auerbach SB, Bialek SR, Hu DJ, Drobeniuc J. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine 2010; 28(16):2860-4; PMID:20153793; http://dx.doi.org/10.1016/j.vaccine.2010.01.059
  • Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008;197(10):1419-26; PMID:18444799; http://dx.doi.org/10.1086/587695
  • Lankarani KB. The necessity of booster vaccination after neonatal hepatitis B vaccination. Hepat Mon 2011; 11(6):419-21; PMID:22087171
  • Young BW, Lee SS, Lim WL, Yeoh EK. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat 2003;10(1):23-30; PMID:12558908; http://dx.doi.org/10.1046/j.1365-2893.2003.00386.x
  • van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, Doherty C, McConkey SJ, Jeffries D, Hall AJ, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006; 193(11):1528-35; PMID:16652281; http://dx.doi.org/10.1086/503433
  • Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 2005; 24(9):786-92; PMID:16148845; http://dx.doi.org/10.1097/01.inf.0000176617.63457.9f
  • McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-41; PMID:15738452; http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008
  • van der Sande MA, Waight PA, Mendy M, Zaman S, Kaye S, Sam O et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. J PLoS One 2007; 8:e753; PMID:17710152; http://dx.doi.org/10.1371/journal.pone.0000753
  • Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, Yang YC, Hung HH, Chu FY. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007;25:8085-90; PMID:17920732; http://dx.doi.org/10.1016/j.vaccine.2007.09.013
  • Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Vaccine 2009; 27:1858-62; PMID:19186203; http://dx.doi.org/10.1016/j.vaccine.2009.01.027
  • Chang HC, Yen CJ, Lee YC, Chiu TY, Jan CF. Seroprevalence of hepatitis B viral markers among freshmen – 20 years after mass hepatitis B vaccination program in Taiwan. J Formos Med Assoc 2007; 106:513-9; PMID:17660140; http://dx.doi.org/10.1016/S0929-6646(07)60001-1
  • Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination. Hum Vaccin 2011; 7(10):1055-9; PMID:21989290; http://dx.doi.org/10.4161/hv.7.10.15990
  • Wu Q, Zhuang G, Wang X, Wang L, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: Results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 2011; 29(12):2302-7; PMID:21277403; http://dx.doi.org/10.1016/j.vaccine.2011.01.025
  • Banatvala JE, Van Damme P. Hepatitis B vaccine – do we need boosters? J Viral Hepat 2003; 10(1):1-6; PMID:12558904; http://dx.doi.org/10.1046/j.1365-2893.2003.00400.x
  • Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28(3):730-6; PMID:19892043; http://dx.doi.org/10.1016/j.vaccine.2009.10.074
  • Gilca V, De Serres G, Boulianne N, Murphy D, De Wals P, Ouakki M, Trudeau G, Massé R, Dionne M. Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine. Vaccine 2013; 31(3):448- 51; PMID:23206974; http://dx.doi.org/10.1016/j.vaccine.2012.11.037
  • Clemens R, Sanger R, Kruppenbacher J, Hobel W, Stanbury W, Bock HL, Jilg W. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule–results of a post-marketing surveillance. Vaccine 1997; 15(4):349-52; PMID:9141203; http://dx.doi.org/10.1016/S0264-410X(96)00205-8
  • Su FH, Chu FY, Bai CH, Lin YS, Hsueh YM, Sung FC, Yeh CC. Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan. J Hepatol 2013; 58(4):684-9; PMID:23207141; http://dx.doi.org/10.1016/j.jhep.2012.11.036
  • Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009; 27:6613-8; PMID:19698812; http://dx.doi.org/10.1016/j.vaccine.2009.08.007
  • Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010; 51:1547-54; PMID:20209603; http://dx.doi.org/10.1002/hep.23543
  • Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, et al. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Vaccine 2009; 27:1858-62; PMID:19186203; http://dx.doi.org/10.1016/j.vaccine.2009.01.027
  • Nakao K, Hamasaki K, Wakihama N, Maeda M, Ohtsubo N, Sagiike T, Ichikawa T, Ishikawa H, Eguchi K, Ishii N. Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus. Vaccine 2003; 21(25-26):3789-94; PMID:12922112; http://dx.doi.org/10.1016/S0264-410X(03)00313-X
  • JJ Wang, YT Qiang, QS Li, ZL Wen, GL Xia, CB Liu. Long-term protection against HBV vaccinated in infancy and immune response in HBV booster trial in adolescence. Chinese Journal of Vaccines and Immunization .2002(4):184-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.